These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

104 related articles for article (PubMed ID: 22286825)

  • 1. A workplace physical activity program at a public university in Mexico can reduce medical costs associated with type 2 diabetes and hypertension.
    Méndez-Hernández P; Dosamantes-Carrasco D; Siani C; Flores YN; Arredondo A; Lumbreras-Delgado I; Granados-García VM; Denova-Gutiérrez E; Gallegos-Carrillo K; Salmerón J
    Salud Publica Mex; 2012; 54(1):20-7. PubMed ID: 22286825
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Medical Expenditure for Chronic Diseases in Mexico: The Case of Selected Diagnoses Treated by the Largest Care Providers.
    Figueroa-Lara A; Gonzalez-Block MA; Alarcon-Irigoyen J
    PLoS One; 2016; 11(1):e0145177. PubMed ID: 26744844
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Analysis of direct medical costs of type 2 diabetes in Mali].
    Alouki K; Delisle H; Besançon S
    Rev Epidemiol Sante Publique; 2017 Feb; 65(1):41-51. PubMed ID: 27889395
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Cost-effectiveness of screening and optimal management for diabetes, hypertension, and chronic kidney disease: a modeled analysis.
    Howard K; White S; Salkeld G; McDonald S; Craig JC; Chadban S; Cass A
    Value Health; 2010; 13(2):196-208. PubMed ID: 19878493
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Trend and factors associated with healthcare use and costs in type 2 diabetes mellitus: a decade experience of a universal health insurance program.
    Cheng JS; Tsai WC; Lin CL; Chen L; Lang HC; Hsieh HM; Shin SJ; Chen T; Huang CT; Hsu CC
    Med Care; 2015 Feb; 53(2):116-24. PubMed ID: 25517075
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Physical activity and healthcare cost of type 2 diabetic patients seen at basic units of healthcare].
    Codogno JS; Fernandes RA; Monteiro HL
    Arq Bras Endocrinol Metabol; 2012 Feb; 56(1):6-11. PubMed ID: 22460189
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Four-year review of presenteeism data among employees of a large United States health care system: a retrospective prevalence study.
    Allen D; Hines EW; Pazdernik V; Konecny LT; Breitenbach E
    Hum Resour Health; 2018 Nov; 16(1):59. PubMed ID: 30413168
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The cost of diabetes mellitus and its impact on health spending in Mexico.
    Villarreal-Ríos E; Salinas-Martínez AM; Medina-Jáuregui A; Garza-Elizondo ME; Núñez-Rocha G; Chuy-Díaz ER
    Arch Med Res; 2000; 31(5):511-4. PubMed ID: 11179587
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Health care costs and financial consequences of epidemiological changes in chronic diseases in Latin America: evidence from Mexico.
    Arredondo A; Zúñiga A; Parada I
    Public Health; 2005 Aug; 119(8):711-20. PubMed ID: 15885723
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The burden of physical activity on type 2 diabetes public healthcare expenditures among adults: a retrospective study.
    Codogno JS; Fernandes RA; Sarti FM; Freitas Júnior IF; Monteiro HL
    BMC Public Health; 2011 May; 11():275. PubMed ID: 21542924
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Medical cost of type 2 diabetes attributable to physical inactivity in the United States in 2012.
    Shah P; Shamoon F; Bikkina M; Kohl HW
    Diabetes Metab Syndr; 2017; 11(1):13-17. PubMed ID: 27377686
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Direct costs of medical care for patients with type 2 diabetes mellitus in Mexico micro-costing analysis].
    Rodríguez Bolaños Rde L; Reynales Shigematsu LM; Jiménez Ruíz JA; Juárez Márquezy SA; Hernández Ávila M
    Rev Panam Salud Publica; 2010 Dec; 28(6):412-20. PubMed ID: 21308167
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The Mental Health in Diabetes Service (MINDS) to enhance psychosocial health: study protocol for a randomized controlled trial.
    O'Brien CL; Ski CF; Thompson DR; Moore G; Mancuso S; Jenkins A; Ward G; MacIsaac RJ; Loh M; Knowles SR; Rossell SL; Castle DJ
    Trials; 2016 Sep; 17(1):444. PubMed ID: 27612943
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Cost of care of arterial hypertension and its impact on the budget assigned to health in Mexico].
    Villarreal-Ríos E; Mathew-Quiroz A; Garza-Elizondo ME; Núñez-Rocha G; Salinas-Martínez AM; Gallegos-Handal M
    Salud Publica Mex; 2002; 44(1):7-13. PubMed ID: 11910723
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The medical cost of cardiometabolic risk factor clusters in the United States.
    Sullivan PW; Ghushchyan V; Wyatt HR; Hill JO
    Obesity (Silver Spring); 2007 Dec; 15(12):3150-8. PubMed ID: 18198326
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Cost of medical care among type 2 diabetic patients with a co-morbid condition--hypertension in India.
    Tharkar S; Satyavani K; Viswanathan V
    Diabetes Res Clin Pract; 2009 Feb; 83(2):263-7. PubMed ID: 19118912
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Six-year cost trends at PPG industries paralleling the introduction of health promotion programs directed at cardiovascular disease prevention.
    Goetzel RZ; Kowlessar NM; Henke R; Benevent R; Tabrizi M; Colombi AM
    J Occup Environ Med; 2013 May; 55(5):483-9. PubMed ID: 23618880
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Out-of-pocket expenses and healthcare resource utilization among individuals with or at risk of diabetes mellitus.
    Fox KM; Grandy S;
    Curr Med Res Opin; 2008 Dec; 24(12):3323-9. PubMed ID: 18954500
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Healthcare costs of people with type 2 diabetes mellitus in the Basque Country (Spain).
    Nuño-Solinís R; Alonso-Morán E; Arteagoitia Axpe JM; Ezkurra Loiola P; Orueta JF; Gaztambide S
    Endocrinol Nutr; 2016 Dec; 63(10):543-550. PubMed ID: 27825534
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Effect of a pharmacist-managed hypertension program on health system costs: an evaluation of the Study of Cardiovascular Risk Intervention by Pharmacists-Hypertension (SCRIP-HTN).
    Houle SK; Chuck AW; McAlister FA; Tsuyuki RT
    Pharmacotherapy; 2012 Jun; 32(6):527-37. PubMed ID: 22552863
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.